dipyridamole has been researched along with Cicatrix in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Cicatrix: The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Requena, L | 1 |
FariƱa, C | 1 |
Barat, A | 1 |
Beller, G | 1 |
1 review available for dipyridamole and Cicatrix
Article | Year |
---|---|
Nuclear cardiology: current indications and clinical usefulness.
Topics: Angina Pectoris; Angioplasty, Balloon; Cardiology; Cardiomyopathies; Cicatrix; Coronary Artery Bypas | 1985 |
1 other study available for dipyridamole and Cicatrix
Article | Year |
---|---|
Degos disease in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Atrophy; Cicatrix; Dipyridamole; Erythema; Homosexuality, Male; | 1998 |